An Innovative and Alternative Technique in Total Colonic Hirschsprung Disease (TCHD) Treatment, Two Case Reports.

With reported occurrences ranging from 1% to 20%, total colonic Hirschsprung disease (TCHD) accounts for about 8% of Hirschsprung disease cases. The selection and sequencing of the surgical approach, access to parenteral nutrition, and collaborative care between surgeons, gastroenterologists, and pathologists are all critical factors in achieving optimal long-term outcomes. Currently, there is no consensus on the best way to treat TCHD patients. Despite the accompanying morbidity and mortality, standardization of care is required.